← FDA Drug Approvals (Drugs@FDA)

BEXAROTENE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UPSHER SMITH LABS · Approved 2018-07-25

Drug application

FDA Application #

ANDA209886

Application type

Abbreviated New Drug Application (Generic)

Brand name

BEXAROTENE

Generic name

BEXAROTENE

Active ingredients

BEXAROTENE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

UPSHER SMITH LABS

Manufacturer

Upsher-Smith Laboratories, Inc.

First approval

2018-07-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown